Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high‐dose methotrexate

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|93|2|E40-E42

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : E40-E42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Practical considerations for the administration of glucarpidase in high‐dose methotrexate (HDMTX) induced renal dysfunction

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1512-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypersensitivity reaction to high‐dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 373-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-dose methotrexate complicated by acute tubular necrosis

By Green Myke R   Chowdhary Sajeel A   Chalmers Lisa M   Lombardi Kris M   Chamberlain Marc C  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 495-497

Future Medicine

Access to resources Recommend Favorite

Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1518-1522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 134-140

Karger

Access to resources Recommend Favorite